
Terumo India, the Indian subsidiary of Terumo Corporation, a leading global medical technology company, has unveiled Occlusafe™ and LifePearl™ for the management of Liver Cancer. Hepatocellular carcinoma (HCC), the primary liver cancer type in India, sees over 20,000 new cases annually. The launch introduces Balloon-TACE (B-TACE), an advanced therapy for liver cancer management. Occlusafe™, Terumo’s B-TACE device, provides precise and targeted chemotherapy delivery to tumors, minimizing damage to surrounding healthy tissues. LifePearl™ facilitates controlled release of chemotherapeutic drugs at the liver's targeted tumor site. These innovations are expected to enhance clinical outcomes for liver cancer patients undergoing TACE treatment.
Like
Save
Share